ATE140003T1 - 1,8-naphthyridin-2-on-derivate - Google Patents

1,8-naphthyridin-2-on-derivate

Info

Publication number
ATE140003T1
ATE140003T1 AT91106040T AT91106040T ATE140003T1 AT E140003 T1 ATE140003 T1 AT E140003T1 AT 91106040 T AT91106040 T AT 91106040T AT 91106040 T AT91106040 T AT 91106040T AT E140003 T1 ATE140003 T1 AT E140003T1
Authority
AT
Austria
Prior art keywords
substituted
lower alkyl
chem
single bond
unsubstituted
Prior art date
Application number
AT91106040T
Other languages
English (en)
Inventor
Fumio Suzuki
Takeshi Kuroda
Kenji Ohmori
Tadafumi Tamura
Hisashi Hosoe
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE140003T1 publication Critical patent/ATE140003T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT91106040T 1990-04-16 1991-04-16 1,8-naphthyridin-2-on-derivate ATE140003T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10000690 1990-04-16

Publications (1)

Publication Number Publication Date
ATE140003T1 true ATE140003T1 (de) 1996-07-15

Family

ID=14262483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91106040T ATE140003T1 (de) 1990-04-16 1991-04-16 1,8-naphthyridin-2-on-derivate

Country Status (9)

Country Link
US (1) US5126341A (de)
EP (1) EP0452873B1 (de)
JP (1) JP2988739B2 (de)
AT (1) ATE140003T1 (de)
CA (1) CA2040517C (de)
DE (1) DE69120581T2 (de)
DK (1) DK0452873T3 (de)
ES (1) ES2093041T3 (de)
GR (1) GR3020848T3 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219864A (en) * 1991-03-12 1993-06-15 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
GB9127252D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
DE4227747A1 (de) * 1992-08-21 1994-02-24 Basf Ag Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9409264D0 (en) * 1994-05-10 1994-06-29 Boots Co Ltd Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
GB9420172D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
EP1847263A3 (de) 2000-12-18 2009-08-26 Institute of Medicinal Molecular Design, Inc. Hemmer für die Produktion und Freisetzung entzündlicher Zytokine
DE10222895A1 (de) * 2002-05-23 2003-12-11 Bosch Gmbh Robert Hochdruckspeicher für Kraftstoffeinspritzsysteme mit integriertem Druckregelventil
EA009523B1 (ru) * 2002-06-05 2008-02-28 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Ингибиторы в отношении активации ар-1 и nfat
EA008769B1 (ru) * 2002-06-05 2007-08-31 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Лекарственное средство для лечения диабета
EA008622B1 (ru) * 2002-06-05 2007-06-29 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Ингибиторы ассоциированной с иммунитетом протеинкиназы
TW200406198A (en) 2002-06-06 2004-05-01 Inst Med Molecular Design Inc O-substituted hydroxyaryl derivatives
CN1658872B (zh) * 2002-06-06 2010-09-22 株式会社医药分子设计研究所 抗过敏药
US20060089395A1 (en) * 2002-06-10 2006-04-27 Susumu Muto Nf-kb activation inhibitors
AU2003242108B2 (en) * 2002-06-10 2008-09-11 Institute Of Medicinal Molecular Design, Inc. Medicament for treatment of cancer
CA2488979A1 (en) * 2002-06-11 2003-12-18 Institute Of Medicinal Molecular Design, Inc. Medicament for treatment of neurodegenerative diseases
CN100417847C (zh) * 2002-11-12 2008-09-10 Nok株式会社 橡胶状弹性部件
ES2393326T3 (es) * 2006-12-18 2012-12-20 Amgen, Inc Compuestos basados en azaquinolona que presentan actividad inhibidora de prolil hidroxilasas, composiciones y usos de los mismos
EP2111399A2 (de) * 2006-12-18 2009-10-28 Amgen Inc. Naphthalenon-verbindungen mit prolylhydroxylase-hemmungsaktivität sowie zusammensetzungen daraus und anwendungen davon
ES2446418T3 (es) * 2007-04-18 2014-03-07 Amgen, Inc Derivados de indanona que inhiben la prolil hidroxilasa
EP2142509B1 (de) * 2007-04-18 2013-12-04 Amgen, Inc Chinolone und azachinolone, die prolylhydroxylase inhibieren
WO2008137084A2 (en) * 2007-05-04 2008-11-13 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
US8030346B2 (en) * 2007-05-04 2011-10-04 Amgen Inc. Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity
EP2855479B1 (de) 2012-04-05 2016-03-30 Boehringer Ingelheim International GmbH 1,8-naphthyridin-2(1h)-on-derivate als cytomegalovirus inhibitoren
BR112022022335A2 (pt) * 2020-05-05 2023-01-10 Teon Therapeutics Inc Moduladores de receptor canabinoide tipo 2 (cb2) e usos dos mesmos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US4264602A (en) * 1975-08-15 1981-04-28 Sandoz, Inc. 4-Hydroxy-3-nitro-pyrido[2,3-B]pyridine-2(1H)-ones
DE2635216A1 (de) * 1975-08-15 1977-03-03 Sandoz Ag 4-hydorxy-3-nitropyrido eckige klammer auf 2,3-b eckige klammer zu pyridin2-one und ihre herstellung
US4128649A (en) * 1977-06-29 1978-12-05 Sandoz, Inc. 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters
US4215123A (en) * 1979-05-07 1980-07-29 American Home Products Corporation Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
DE3368929D1 (de) * 1982-04-26 1987-02-12 Schering Corp 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
CA1305478C (en) * 1986-11-06 1992-07-21 Margaret H. Sherlock Naphthyridine and pyridopyrazine compounds and pharmaceutical usage thereof

Also Published As

Publication number Publication date
ES2093041T3 (es) 1996-12-16
DE69120581T2 (de) 1996-10-31
JP2988739B2 (ja) 1999-12-13
JPH04217981A (ja) 1992-08-07
DE69120581D1 (de) 1996-08-08
DK0452873T3 (da) 1996-07-29
CA2040517C (en) 1997-06-03
CA2040517A1 (en) 1991-10-17
EP0452873A1 (de) 1991-10-23
GR3020848T3 (en) 1996-11-30
EP0452873B1 (de) 1996-07-03
US5126341A (en) 1992-06-30

Similar Documents

Publication Publication Date Title
DE69120581D1 (de) 1,8-Naphthyridin-2-on-Derivate
DE3773660D1 (de) Morpholinoethylester von mycophenolsaeure und ihre derivate, ihre herstellung und verwendung in pharmazeutische zusammensetzungen.
NO174711C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater
NO179142C (no) 3-benzyliden-1-karbamoyl-2-pyrrolidon-analoger
CA2124680A1 (en) Piperazine derivatives as 5-ht1a antagonists
FI892497A0 (fi) Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi
DK0790987T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
ATE252074T1 (de) Phenylalkylcarbonsäure-derivate
ATE99295T1 (de) Benzimidazol-derivate mit pharmakologischer aktivitaet.
FI900461A0 (fi) Imidazopyridaziner, deras framstaellning och anvaendning.
NO940312D0 (no) Nytt bisheterocyklisk derivat eller salt derav
IS3828A (is) Hliðstæð aðferð til tilreiðslu á nýjum afleiðum thiazolidinone og oxazolidinone sem gagnlegar eru til æðaútvíkkunar
IT1216522B (it) Derivati alchiltiobenzimidazolici attivi farmacologicamente eprocedimento per la loro preparazione.
ATE160562T1 (de) Piperazinderivate
DE69300318D1 (de) Flavonderivate.
ATE73801T1 (de) Heterocyclische oxophthalazinylessigsaeure.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee